The aim of this study was to investigate the association between high on-treatment platelet reactivity (HPR) and the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score (SS) for risk prediction of major adverse cardiovascular events (MACE) in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS) undergoing percutaneous coronary intervention (PCI).
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study / Palmerini, T.; Calabro, P.; Piscione, F.; De Servi, S.; Cattaneo, M.; Maffeo, D.; Toso, A.; Bartorelli, A.; Palmieri, C.; De Carlo, M.; Capodanno, D.; Barozzi, C.; Tomasi, L.; Della Riva, D.; Mariani, A.; Taglieri, N.; Reggiani, L.B.; Bianchi, R.; De Rosa, R.; Mariani, M.; Podda, G.; Genereux, P.; Stone, G.W.; Angiolillo, D.J.. - In: JACC: CARDIOVASCULAR INTERVENTIONS. - ISSN 1936-8798. - STAMPA. - 7:10(2014), pp. 1117-1127. [10.1016/j.jcin.2014.04.020]
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study
BAROZZI, CHIARA;TOMASI, LUCIANA;DELLA RIVA, DIEGO;MARIANI, ANDREA;TAGLIERI, NEVIO;BACCHI REGGIANI, MARIA LETIZIA;
2014
Abstract
The aim of this study was to investigate the association between high on-treatment platelet reactivity (HPR) and the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score (SS) for risk prediction of major adverse cardiovascular events (MACE) in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS) undergoing percutaneous coronary intervention (PCI).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.